Contrarian Corpus
Pershing Square vs. Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. · PSH

6 decks published between 2018-01-29 and 2026-02-11 — 395 pages, 337 analysed slides total. Outcome: ongoing.

follow up

Timeline

Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.

  1. 2018-01-29 follow up

    2018 01 2018 Annual London Investor Presentation_FINAL

    58pp · full_deck

    After a -4% 2017, Pershing Square restructures to a leaner investment-centric team, reaffirms core principles, and launches a $300mm PSCM tender to close PSH's ~20% NAV discount.

    N 2 V 3 C 2
  2. 2019-02-13 follow up

    2019 02 2019 Annual Investor Update Presentation

    58pp · full_deck

    PSH offers an activist portfolio compounding well above the S&P 500, available at a 27% discount to NAV, with a new dividend, buybacks, and insider buying narrowing the gap.

    N 3 V 3 C 3
  3. 2021-02-18 follow up

    2021 02 PSH 2021 Annual Investor Presentation

    57pp · full_deck
    N 2 V 3 C 3
  4. 2023-02-09 follow up

    2023 02 2023 Annual Investor Presentation

    62pp · full_deck

    PSH's hedging-led 2022 outperformance and 25%+ five-year compounding deserve a narrower discount to NAV; buybacks, rising dividend and FTSE 100 inclusion are closing the gap.

    N 2 V 3 C 2
  5. 2025-02-11 follow up

    2025 02 2025 Annual Investor Presentation_PSH_vDF

    75pp · full_deck

    Fund-level recap: PSH's 22.9% seven-year NAV CAGR, conservative leverage and PSCM stake sale set up a narrowing of the persistent ~30% discount to NAV.

    N 2 V 3 C 3
  6. 2026-02-11 follow up

    2026 02 2026 Annual Investor Presentation

    85pp · full_deck

    Pershing Square's 22.6% 8-year NAV CAGR validates the permanent-capital model; 2025's 33.9% TSR narrowed the NAV discount and the HHH/Vantage transformation extends the compounding runway.